Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
3,531
Funds Holding Change
+233
Funds Holding Growth
+7%
Value
$1.08T
Holding in Top 10
1,422
Top 10 Change
+210
Top 10 Growth
+17%
Value Growth
-5%
New
360
Increased
1,255
Reduced
1,729
Closed
89
Capital Inflow
$37.7B
Capital Outflow
$34.5B
Net Capital Flow
+$3.16B
Capital Flow Change
+$2.98B
Calls
$11.2B
Puts
$12.5B
Net Calls
-$1.35B
Put/Call Ratio
1.12